DOYLESTOWN, PA — Hatch BioFund has invested in Optimeos Life Sciences, a Princeton University spinout developing a nanoparticle platform for delivering gene therapies and other biologic medicines, expanding the Pennsylvania …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.